FDA Grants Approval for Tofacitinib Citrate ANDA218821 by Concord Biotech
The FDA has granted approval for ANDA218821, a generic version of tofacitinib citrate submitted by Concord Biotech.
Company
Pharmaceutical intelligence for Concord Biotech with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.